RaQualia Pharma Inc. (TYO:4579)

RaQualia Pharma Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 3, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	13,452	8,386	14,874	25,843	24,601	20,952
Market Cap Growth	4.21%	-43.62%	-42.44%	5.05%	17.42%	-25.38%
Enterprise Value	13,026	8,784	11,061	22,330	21,890	18,543
Last Close Price	550.00	384.00	688.00	1232.00	1174.00	1000.00
PE Ratio	-	-	-	35.74	32.58	-
Forward PE	-	15.07	19.50	74.48	78.27	91.95
PS Ratio	4.16	2.70	7.83	8.86	8.86	18.93
PB Ratio	2.14	1.51	2.43	4.70	5.14	5.23
P/TBV Ratio	5.41	5.03	2.44	4.72	5.18	5.27
P/FCF Ratio	-	99.83	-	17.84	89.79	-
P/OCF Ratio	200.77	46.59	-	17.46	67.22	-
EV/Sales Ratio	4.03	2.83	5.82	7.65	7.89	16.75
EV/EBITDA Ratio	56.88	46.72	-	22.02	25.78	-
EV/EBIT Ratio	-	-	-	25.76	30.92	-
EV/FCF Ratio	-289.47	104.57	-	15.41	79.89	-
Debt / Equity Ratio	0.51	0.62	0.06	0.04	0.01	0.01
Debt / EBITDA Ratio	13.95	18.35	-	0.22	0.04	-
Debt / FCF Ratio	-	41.07	-	0.15	0.14	-
Asset Turnover	0.32	0.38	0.29	0.51	0.59	0.24
Inventory Turnover	4.56	3.98	3.16	25.67	40.13	25.09
Quick Ratio	4.24	3.40	11.22	9.18	9.66	14.21
Current Ratio	4.80	3.82	12.74	9.78	10.01	15.24
Return on Equity (ROE)	-8.82%	-8.47%	-5.56%	14.06%	17.17%	-14.05%
Return on Assets (ROA)	-1.56%	-1.61%	-3.21%	9.43%	9.33%	-6.69%
Return on Capital (ROIC)	-1.66%	-1.72%	-3.45%	10.28%	9.97%	-7.00%
Return on Capital Employed (ROCE)	-	-	-	15.00%	14.60%	-
Earnings Yield	-3.91%	-5.90%	-2.17%	2.80%	3.07%	-2.89%
FCF Yield	-0.33%	1.00%	-6.21%	5.61%	1.11%	-2.09%
Buyback Yield / Dilution	-3.04%	-0.16%	-2.97%	-0.05%	-0.10%	-1.62%

Updated Jun 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.